The insulin-like growth factor II/mannose 6-phosphate receptor (IGF2R) interacts with lysosomal enzymes through two binding domains in its extracytoplasmic domain. We reported in a previous paper that only one of the two extracytoplasmic mannose 6-phosphate (Man-6-P) binding domains is necessary for high-affinity Man-6-P ligand binding, suggesting that like the cation-dependent Man-6-P receptor, oligomerization of the IGF2R contributes to high-affinity interaction with lysosomal enzymes. In the present study, we have directly characterized both naturally occurring and engineered forms of the IGF2R for their ability to form oligomeric structures. Whereas gel filtration chromatography suggested that purified bovine IGF2R species exist in a monomeric form, native gel electrophoresis allowed for the separation of dimeric and monomeric forms of the receptors with distinct phosphomannosyl ligand binding characteristics.
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ligand binding as well (21) . Finally, receptor oligomerization confers high-affinity Man-6-Pspecific lysosomal enzyme binding on the related cation-dependent mannose-6-phosphate receptor (CD-MPR) (22) . These examples suggest that the oligomeric state of the IGF2R may be important in the overall function of this ubiquitously expressed receptor. In this report, we have studied the ability of the IGF2R to form dimeric complexes in the presence and absence of Man-6-P ligands using both naturally occurring forms of the IGF2R as well as human IGF2R constructs encompassing portions of the receptor's extracytoplasmic domain. The natural state of the IGF2R appears to be a constitutive dimer, as this receptor formed oligomeric complexes through its extracytoplasmic domain in a ligand-independent manner.
by guest on September 1, 2017 http://www.jbc.org/ Downloaded from 7 was then washed 5 times with 5 ml of column buffer containing 5 mM glucose 6-phosphate. The bound sIGF2R was then eluted from the column with 25 ml of column buffer containing 10 mM Man-6-P. Fractions containing the sIGF2R were pooled and lyophilized. Purification of the sIGF2R yielded about 7-10 mg of protein per liter of FBS, determined by Coomassie blue staining of samples analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
The full-length IGF2R was purified from bovine liver according to a modified procedure of York et al. (17) . After homogenization of 220 g of bovine liver and extraction in a buffer containing 50 mM imidazole, pH 7, 150 mM NaCl, 5 mM b-glycerol phosphate, 2% Triton X-100, 0.25% sodium deoxycholate, 10 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 20 mg/ml aprotinin, 10 mg/ml antipain, 80 mg/ml benzamidine, and 10 mg/ml leupeptin, the full-length IGF2R was affinity-purified on PMP-Sepharose as described for the soluble receptor. Samples containing the receptor were lyophilized and stored at -20°C until use. This procedure yielded about 1.5 mg of purified IGF2R, as determined by Coomassie blue staining of material analyzed by SDS-PAGE. After affinity purification, aliquots of the lyophilized IGF2R species (approximately 0.75 mg) were dissolved in 150 mM ammonium acetate, 250 mM acetic acid, pH 4.5 and applied to a 20-ml Superose 12 column equilibrated under the same acidic conditions as described by Valenzano et al. (26) . Elution of the purified receptor was monitored by both absorbance at 280 nm and with SDS-PAGE of the fractions and Coomassie blue staining (data not shown). This acidic gel filtration step was used to remove any Man-6-P and other phosphomannosylated ligands that may have copurified with the IGF2R during the affinity chromatography. Fractions containing the receptors were lyophilized and stored at -20 °C until use. Fast protein liquid chromatography and native gel analysis of purified bovine receptors. The oligomeric state of both the sIGF2R and full-length IGF2R species was analyzed with fast protein liquid chromatography (FPLC) analysis on an analytical 20 ml Superose-12 column ( Pharmacia Biotech, Piscataway, NJ) equilibrated with column buffer (50 mM imidazole, pH 7.4, 150 mM NaCl, 5 mM sodium b-glycerophosphate, and 0.05% Triton X-100).
Aliquots (0.2 mg) of the lyophilized, affinity-purified receptors were resuspended in 0.2 ml of water and run on the column. Elution of the purified receptor was monitored by absorbance at 280 nm. Stokes radius measurements were made by comparing elution profiles of the receptors to those of protein standards: thyroglobulin, ferritin, catalase, aldolase, and bovine serum albumin (BSA) (Pharmacia Biotech).
Native gel electrophoresis of the receptors was carried out by a modified procedure of Kuehn et al. (27) . Aliquots (1 -10 mg protein) of sIGF2R or IGF2R directly eluted from the PMP-Sepharose column were electrophoresed on native PAGE composed of a 4-12% linear gradient containing 0.1% Triton X-100. After electrophoresis, protein was detected with Coomassie blue staining. Stokes radius estimates were made by comparing the mobility of the receptor to that of native gel standards (Pharmacia Biotech). To determine the role that Man-6-P and other phosphomannosylated ligands play in the topology of the receptor's extracytoplasmic domain, aliquots (0.5 mg) of the purified soluble IGF2R were resuspended in water and dialyzed for 24 h against HBST (25 mM HEPES, pH 7.4, 150 mM NaCl, 0.05% Triton X-100) using Slide-A-Lyzer cassettes (Pierce, Rockford, IL) to remove the Man-6-P. In addition, a pseudoglycoprotein containing multiple Man-6-P moieties, PMP-BSA, was synthesized as previously reported (23) . Aliquots of the purified sIGF2R (1-10 mg protein) were incubated with a range of PMP-BSA concentrations (from 1 -8000 nM) in 30 ml HBST for 3 h at 3°C and then subjected to native PAGE or cross-linked with 2.5 mM disuccinimidyl suberate (Pierce) at 3°C for 15 min and resolved by 6% reducing SDS-PAGE followed by coomassie blue staining.
Western Ligand Blotting. Ligand blotting was performed using a modified procedure published earlier for the detection of IGF-binding proteins (28) . The purified sIGF2R and fulllength IGF2R (~ 1 mg for each lane) were electrophoresed on native 4-12% gradient gels as described above, then transferred to BA85 nitrocellulose (Schleicher and Schuell, Keene, NH).
The blots were washed and blocked with 1% BSA. Affinity for IGF-II and PMP-BSA was detected by probing the blots with 1.5 ´ 10 6 cpm 125 I-PMP-BSA or 125 I-IGF-II in 8 ml of blocking solution for 16 h at 3°C. The blots were then washed and exposed to x-ray film.
Intensity of ligand binding was determined using a densitometer with ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Preparation and expression of truncated IGF2R constructs.
A soluble construct containing all 15 extracytoplasmic repeats of the IGF2R followed by a FLAG epitope, 15F, was engineered using the hIGF2R cDNA as previously described (23) . A similar construct, 15myc, was generated using the same strategy with a COOH-terminal Myc epitope-tag (MEQKLISEEDLN) (29) engineered in place of the FLAG-tag. Transient expression of these truncated constructs was done by calcium phosphate precipitation following a previously described method in 293T human embryonic kidney cells (23) . Coexpression of the 15F and 15myc constructs was performed by mixing equal amounts of the cDNAs (30 mg each per 100-mm dish containing approximately 2.5 million cells) prior to transfection. Serum-free conditioned media (24 h) and 1% Triton X-100 cell lysates were prepared on the 5 th or 6 th day after transfection as previously described (30) . To confirm expression of the FLAG-and Myctagged constructs, aliquots of both conditioned media (75 ml) or cell lysates (30 ml) were analyzed by immunoblotting with either the a-FLAG M2 antibody or the a-Myc 9E10 monoclonal antibody, or both, using a previously reported procedure (23) .
Coimmunoprecipitation of the 15F and 15myc constructs. The ability of the FLAGand Myc-tagged receptor constructs to interact was measured in a coimmunoprecipitation procedure (23) . Routinely, aliquots of cell lysates (20-40 ml) containing the expressed constructs were incubated with 12 ml packed M2 a-FLAG resin in 25 mM HEPES, pH 7.4, and 150 mM NaCl (HBS) with 0.5% BSA at 3°C for 2-4 h. Following immunoadsorption, the resin pellets were collected by centrifugation at 14,000 x g for 10 s and then washed twice with 0.75 ml of HBST. The resultant resin pellets could then be analyzed by immunoblotting to determine if the FLAG-and Myc-tagged receptor constructs were capable of coimmunoprecipitation.
In order to study the dynamics of complex formation between the 15F and 15myc
constructs in vitro, each species was purified separately from transiently transfected 293T cells on PMP-Sepharose affinity columns, as has been described for the soluble IGF2R above. The constructs were eluted from the affinity columns using 10 mM Man-6-P, lyophilized, and stored at -20°C until use. Aliquots of the purified receptor constructs were mixed and incubated for increasing lengths of time (0-8 h) at 37°C. The amount of 15F and 15myc present in a complex was measured using the coimmunoprecipitation procedure described above.
Preparation of FLAG-tagged IGF2R/EGFR chimeric receptor constructs and a
Myc-tagged IGF2R. The cytoplasmic domain of the human epidermal growth factor receptor (EGFR) was fused to the extracytoplasmic and transmembrane domains of the IGF2R to create a chimeric IGF2R/EGFR construct. A construct containing the IGF2R cDNA, lacking the Eag I fragment between nt 162 -5319 (23) , was used as a template for amplification by Vent™ polymerase using a 5' primer containing a Kpn I restriction site preceding the sequence corresponding to nt 94-113 of the IGF2R cDNA and a 3' primer that represented sequence complementary to nt 7114-7134 followed by a Hind III site. The resultant product of the amplification was digested with Kpn I and Hind III and subcloned into pCMV5. Next, the Eag I fragment from the wild-type IGF2R cDNA was subcloned in, completing the extracytoplasmic portion of the IGF2R half of the chimera. Finally, the cytoplasmic domain of the EGFR was amplified using Pfu polymerase with the variant III human EGFR cDNA (EGFRvIII) as a template and two primers. The 5'-primer contained a Hind III site followed by sequence corresponding to nt 2206-2221 of the human EGFR cDNA (31) , and the 3'-primer was complementary to nt 3802-3813 followed by the FLAG epitope, a UAG stop codon, and an Xba I site. The resultant product was digested with Hind III and Xba I and subcloned into the pCMV5 vector containing the IGF2R portion of the chimera, completing the construct.
The 11-TM/EGFR and 13-TM/EGFR chimeras were prepared utilizing a similar strategy.
The region of the IGF2R extracytoplasmic domain to be included in these constructs was amplified from the full-length IGF2R cDNA using 5'-primers containing an EcoR I site followed by sequence corresponding to nt 4675-4692 for the 11-TM/EGFR or nt 5542-5560 for the 13- Finally, the wild-type Eag I fragment was subcloned in, completing the IGF2Rmyc construct. Dulbecco's modified Eagle medium (DMEM) or DMEM containing 5 mM Man-6-P, 25 nM PMP-BSA, or 5 mM Glc-6-P. To ensure a consistent level of exogenous ligands, the cells were again fed with media containing 5 mM Man-6-P, 25 nM PMP-BSA, or 5 mM Glc-6-P 3 h prior to collection of cell lysates at 51 h after transfection. Cell lysates were prepared following the procedure of Meng and Lin (32) . Each 100-mm dish of 293T cells was scraped and the cells were washed with 2 ml of ice-cold HBS and then lysed in 400 ml of ice-cold lysis buffer containing phosphatase and protease inhibitors (20 mM HEPES, pH 7.5, 0.1% SDS, 0.5% deoxycholate, 1%
Expression of chimeras and
Nonidet P-40, 150 mM NaCl, 4 mM ethylenediaminetetraacetic acid, 10 mM NaF, 0.1 mM ZnCl 2 , 10 mM Na 4 P 2 O 7 , 2 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 20 mg/ml aprotinin, 10 mg/ml antipain, 80 mg/ml benzamidine, and 10 mg/ml leupeptin). Aliquots (20 ml) were then subjected to immunoblot analysis with the a-FLAG or a-Myc antibodies and developed with 125 I-protein A to determine the relative levels of expression via PhosphorImager analysis.
Analysis of the phosphorylation and coimmunoprecipitation of transiently
expressed chimeras and IGF2Rmyc. Equimolar amounts of the chimeric receptor constructs from cell lysates of each transfection set, or 30 ml of pCMV5-transfected control cell lysates, were immunoadsorbed to 15 ml of a-FLAG M2 resin in the presence of HBS + 1% BSA for 2.5 h at 3°C. The pellets were then collected and washed twice with 0.75 ml of ice-cold HBST. They were then electrophoresed on reducing 6% SDS-PAGE gels and transferred to BA 85 nitrocellulose. The blots were then subjected to the immunoblot procedure with either a-FLAG M2 antibody, a-Myc 9E10 antibody, or the a-phosphotyrosine (a-PY) 4G10 antibody (Upstate Biotechnology, Lake Placid, NY) and developed by 125 I-protein A followed by autoradiography.
Results:
Analysis of purified bovine sIGF2R and full-length IGF2R by gel filtration FPLC and native gel electrophoresis. Two naturally occurring forms of the IGF2R were purified from bovine sources so that they could be analyzed for the ability to form oligomeric structures. The soluble form of the IGF2R, which is present in the serum of several species (26, (33) (34) (35) , and fulllength IGF2R were purified from FBS and Triton X-100 liver extracts, respectively, by PMPSepharose affinity chromatography. The receptors were eluted from the PMP-Sepharose columns with 10 mM Man-6-P, and fractions were analyzed by SDS-PAGE under reducing conditions followed by Coomassie blue staining to detect the purified product (Fig. 1A) . The purified forms demonstrated a major band at the appropriate molecular weights --250,000 for the sIGF2R and 300,000 for the full-length IGF2R. The minor bands of lower molecular weight were not observed when the gels were run under non-reducing conditions, suggesting that they are cleavage products of the receptor (data not shown). In order to estimate the Stokes radii of the two different receptor species, they were first analyzed by gel filtration chromatography on a 20-ml Superose 12 FPLC column (Fig. 1B) . Despite their apparent purity, both species eluted with heterogeneous peaks that spanned wide size distributions. The major peak of the full-length IGF2R eluted from the column with a Stokes radius of approximately 66 Å, which is lower than previous reports of 79 Å (17) and 72 Å (36) for the monomeric bovine IGF2R. Surprisingly, the major peak of the sIGF2R demonstrated a much lower Stokes radius of about 49 Å.
The second method used to determine the structure of the IGF2R was native gel To determine if the possible presence of phosphomannosylated proteins bound to the receptor may have had an impact on the amount of sIGF2R dimer detectable by the native gel analysis, aliquots (~10 mg) of purified sIGF2R that had been dialyzed to remove the Man-6-P were incubated in the presence of 1-8000 nM PMP-BSA. Following a 3-h incubation at 3°C, the samples were either directly resolved by native gel electrophoresis or were cross-linked with 2.5 mM disuccinimidyl suberate and resolved on a 6% reducing SDS-PAGE gel followed by Coomassie blue staining. Approximately 10% of the sIGF2R was cross-linked as a dimer (data not shown), and the addition of increasing concentrations of PMP-BSA had no effect on the amount of dimer detected by either procedure (data not shown).
The monomeric and dimeric IGF2R display different affinities for PMP-BSA.
Separation of the monomeric and dimeric forms of the bovine IGF2Rs using native-PAGE allowed us to probe their ability to bind 125 I-PMP-BSA and 125 I-IGF-II. After native gel electrophoresis, the protein was transferred to nitrocellulose, and the blots were then incubated IGF2R dimer was the only form of the receptor that could interact with high affinity (Fig. 2A) .
Binding of 125 I-PMP-BSA to the monomeric form of the full-length receptor was detected, but required a 10-fold longer exposure to x-ray film (data not shown). Likewise, albeit not as marked an effect, the soluble receptor demonstrated a 6-fold higher stoichiometry of PMP-BSA binding to the dimeric form than would be predicted from the Coomassie blue staining and 125 I-IGF-II ligand blot (Fig. 2B ).
Epitope-tagged soluble receptor constructs are capable of forming non-covalent complexes when coexpressed in 293T cells. In view of the opposing findings on the receptor size estimates obtained by gel filtration FPLC analysis and native gel electrophoresis, we were compelled to determine the oligomeric nature of the IGF2R by yet another approach. Two soluble constructs, 15F and 15myc, were engineered to contain the extracytoplasmic domain of the IGF2R followed by either a FLAG or Myc epitope-tag. These constructs were expressed alone or coexpressed by mixing their cDNAs prior to calcium phosphate transfection in 293T cells. On the 5 th or 6 th day after addition of the cDNAs to the cell culture, cell extracts were prepared, and expression was confirmed by immunoblot using the a-FLAG or the a-Myc antibodies ( Fig 3A) .
To determine if the coexpressed receptor constructs exist in an oligomeric complex, cell lysates containing the constructs were immunoadsorbed to a-FLAG resin in the presence or absence of 1 mM IGF-II or 5 mM Man-6-P. The resin pellets were then washed to remove unbound construct, loaded onto a reducing SDS-PAGE gel, and analyzed by immunoblotting with the a-Myc antibody to determine if the 15myc receptor construct interacts with the 15F construct (Fig. 3B) . Neither the 15F nor the 15myc constructs were detected in the immunoblot analysis of lysates from cells transfected with either construct alone, but the cell lysates containing the coexpressed receptor constructs showed that the 15myc and 15F proteins form a non-covalent complex when they are expressed together. Surprisingly, the addition of exogenous IGF-II or Man-6-P did not affect the amount of complex formed when added during the immunoprecipitation. PhosphorImager analysis of the blot revealed that approximately 50% of the expressed 15myc coimmunoprecipitated with 15F, suggesting that the majority of the 15myc existed as either 15myc homodimers or as heterodimers with the 15F construct.
To determine if the interaction between the 15F and 15myc receptors could occur after mixing the proteins in vitro, each construct was purified separately by PMP-Sepharose affinity chromatography. Aliquots (50-100 ml) of the purified receptor constructs were mixed and incubated for increasing lengths of time (from 0-8 h) at 37°C prior to immunoprecipitating with a-FLAG resin, and the presence of coimmunoprecipitated 15myc protein was detected by immunoblotting with the a-Myc antibody ( extracytoplasmic and transmembrane domains fused to the cytoplasmic domain of the human EGFR followed by a FLAG-epitope tag (Fig. 4) . The rationale behind these experiments was based on the observation that the extracytoplasmic domain of the IGF2R was capable of mediating receptor oligomerization in a ligand-independent manner. If this oligomerization occurred in the cell membrane, then the chimeric proteins should exhibit ligand-independent autophosphorylation of tyrosyl residues in their EGFR-derived cytoplasmic domain, due to transphosphorylation (37) . The first chimera studied contained the entire IGF2R extracytoplasmic domain fused to the EGFR cytoplasmic domain. This construct, called the IGF2R/EGFR chimera, was transiently expressed in 293T cells so that its tyrosine phosphorylation level could be measured. Parallel transfections were also carried out with the chimera and a human IGF2R cDNA containing a c-Myc epitope tag at its carboxyl terminus. One day after the addition of the cDNAs, and again 3 h prior to preparation of cell lysates, the transfection medium was replaced with serum-free medium containing either Man-6-P, PMP-BSA, or Glc-6-P to test the ability of these ligands to influence the phosphotyrosine levels of the chimera.
To measure the phosphorylation of the IGF2R/EGFR chimera under the different conditions, the cell lysates were immunoadsorbed to M2 a-FLAG resin and analyzed by immunoblotting with either a-FLAG or a-phosphotyrosine (a-PY) antibodies (Fig. 5) . Lysates from cells transfected with pCMV5, the chimera, or the chimera plus the IGF2Rmyc construct were also subjected to direct immunoblot analysis using an a-Myc antibody to confirm the expression of the IGF2Rmyc construct. As predicted for an oligomeric complex, the IGF2R/EGFR chimera demonstrated a strong signal with the a-PY antibody, indicating its phosphorylation on tyrosine. However, the addition of Man-6-P, Glc-6-P, and PMP-BSA had no effect on the basal level of phosphorylation. On the other hand, overexpression of IGF2Rmyc with the chimera almost completely eliminated phosphorylation of the chimera (Fig. 5) .
To further investigate the relationship between heterodimer formation and phosphorylation of the chimera, another series of transfections was conducted using equal amounts of the chimera cDNA mixed with increasing amounts of IGF2Rmyc. Equal amounts of the cell lysates were analyzed by a-FLAG and a-Myc immunoblotting, revealing that mixing the IGF2Rmyc cDNA at increasing ratio with a constant amount of the IGF2R/EGFR chimera resulted in a gradient of expression of the IGF2Rmyc with a modest effect (30% maximal reduction) on the expression of the chimera (Fig. 6A) . The ability of IGF2Rmyc to interact with the chimera, and the effect this interaction has on the phosphorylation of the chimera, was next measured by immunoprecipitating the chimera from cell lysates with the a-FLAG resin and then immunoblotting with either the a-FLAG, a-PY, or a-Myc antibodies (Fig. 6B) . Even in the presence of the harsh conditions imposed by the cell lysis buffer (0.1% SDS, 0.5% sodium deoxycholate, and 1% Nonidet P-40), IGF2Rmyc coimmunoprecipitated with the chimera. In addition, the inhibition of chimera phosphorylation correlated directly with the amount of
IGF2Rmyc that was complexed with the chimera.
Man-6-P binding domains are not required for dimerization of the IGF2R/EGFR
constructs. Two IGF2R/EGFR constructs were engineered bearing deletions of the Man-6-P by guest on September 1, 2017
http://www.jbc.org/ Downloaded from binding domains of the IGF2R extracytoplasmic domain (Fig. 4) . The 11-TM/EGFR construct contains repeats 11-15 and the transmembrane domain of the IGF2R fused to the cytoplasmic domain of the EGFR. The other construct, called 13-TM/EGFR, contains repeats 13-15 and the transmembrane domain of the IGF2R fused to the EGFR cytoplasmic domain. These constructs were expressed either alone or with the IGF2Rmyc construct in 293T cells, as was described above for the full-length IGF2R/EGFR chimera. An unrelated FLAG-tagged construct, encoding kinase suppressor of ras (KSRF), was also expressed with IGF2Rmyc as a negative control.
These expressed constructs were immunoprecipitated with the a-FLAG resin and then subjected to immunoblot analyses with the a-FLAG, a-PY, and a-Myc antibodies to determine if they display similar characteristics as the full-length IGF2R/EGFR construct (Fig. 7) . Both the 11-TM/EGFR and the 13-TM/EGFR were capable of being translated into proteins with sizes appropriate for their predicted molecular weights. Like the full-length IGF2R/EGFR chimera, the 11-TM/EGFR when expressed on its own demonstrated a strong level of tyrosine phosphorylation, which was inhibited by coexpression of the IGF2Rmyc construct. The 13-TM/EGFR chimera also demonstrated high levels of tyrosine phosphorylation when expressed alone. Surprisingly, coexpression of the IGF2Rmyc did not affect the level of the 13-TM/EGFR phosphorylation. However, the 13-TM/EGFR chimera did interact with IGF2Rmyc, as demonstrated by coimmunoprecipitation analysis (Fig. 7 ). Based on the expression level of IGF2Rmyc in the cotransfected cell lysates, the amount of IGF2Rmyc that interacted with 13-TM/EGFR was 32 ± 11% (n=4) lower than that bound by 11-TM/EGFR.
Discussion:
One of the major obstacles in demonstrating the dimeric structure of the IGF2R is that, as previously reported, when measured by sucrose gradient and gel filtration techniques in the absence of bivalent phosphomannosylated ligands, detergent-solubilized IGF2R appears to exist primarily as a monomer (17, 18) . Analysis of purified soluble and full-length IGF2R species by gel filtration on a Superose-12 FPLC column, reported herein, demonstrated that the full-length receptor has a Stokes radius of 66 Å, which is somewhat smaller than previous reports of 79 Å for the full-length bovine receptor (17) and 72 Å for the full-length rat receptor (18) . Sucrose gradient centrifugation of these purified receptor species suggested that they were monomeric receptors with calculated molecular weights of 334,000 (17) and 290,000 (18) , respectively. The large Stokes radius of the receptor in relation to its predicted molecular weight suggests that it is not globular in shape, but rather exists in a cigar-shaped conformation under these conditions.
The sIGF2R, reported here, demonstrated a Stokes radius that was 26% smaller than the fulllength receptor in the gel filtration analysis, even though this species is lacking only a small portion of the carboxyl terminus (35). This observation could be explained if the extracytoplasmic portion of the IGF2R alone folds into a globular protein under these experimental conditions. Thus, the ellipsoid character of detergent-solubilized IGF2R may require the presence of the transmembrane and cytoplasmic domains.
Analysis of the full-length IGF2R by native gel electrophoresis, using the same sample preparation as was loaded onto the Superose-12 column, resulted in quite different hydrodynamic behavior. Under these conditions, the monomeric form of the full-length receptor demonstrated a Stokes radius identical to that measured by the FPLC analysis, but the majority of the receptor was present as a much larger complex with a Stokes radius greater than 85 Å, suggesting a dimeric form of the receptor. Even when the receptor was further purified under acidic conditions that would be expected to promote dissociation of phosphomannosyl ligands, the dimeric form persisted, suggesting that exogenous ligands are not necessary for dimer formation. One of the major differences between the FPLC analysis and the native gel was the pH. The FPLC analysis was conducted at a pH of 7.4, whereas the native gel electrophoresis was conducted using the Laemmli method at a pH of 6.8 in the stacking gel and a pH of 8.3 in the resolving gel (38) . However, it is difficult to explain these observations based solely on the differences in pH.
While this study was ongoing, York et al. (17) reported that the addition of a multivalent
Man-6-P-bearing lysosomal enzyme to the gel filtration analysis resulted in an increase in size of the IGF2R, with a Stokes radius consistent with a dimeric complex of the IGF2R bound to a single ligand. In light of the conflicting results from the FPLC and native gel analyses reported herein, the observation of York et al. (17) suggests that ligand occupancy of the IGF2R may increase the stability of the dimeric complex so that it remains intact during gel filtration.
However, when we incubated purified sIGF2R in the presence of 1-8000 nM PMP-BSA prior to native gel electrophoresis, we found no change in the relative ratios of dimeric to monomeric complexes (data not shown). Whereas it seems likely that ligand occupancy increased the stability of IGF2R dimers, these data suggest that the amount of preformed sIGF2R dimer is not influenced by the presence of multivalent ligand.
The discrepancy between the FPLC analysis and native gel electrophoresis compelled us to address the oligomeric nature of the IGF2R using other techniques. In the first approach, we used two truncated soluble IGF2R constructs bearing different epitope tags. Both constructs contained all 15 repeats of the extracytoplasmic domain followed by a FLAG or Myc epitope tag, called 15F and 15myc, respectively. The use of unique epitope tags allowed identification of heterooligomers by immunoprecipitation with the a-FLAG antibody and immunoblotting with the a-Myc antibody. When transiently coexpressed in 293T cells, these truncated receptors exist as heterocomplexes in 1% Triton X-100 cell lysates. Surprisingly, the addition of either exogenous PMP-BSA or IGF-II had no effect on the amount of complex measured using coimmunoprecipitation techniques. Nearly 50% of the 15myc that was coexpressed with 15F
was coimmunoprecipitated with the anti-FLAG antibody, which would be the predicted result if all of the 15F and 15myc constructs exist as either homodimers or heterodimers with a 1:2:1 Gaussian distribution.
To determine if the 15F and 15myc constructs are capable of interacting outside of the cell, they were purified separately on PMP-Sepharose affinity columns. When these purified constructs were mixed in the presence of approximately 10 mM Man-6-P, they demonstrated no interaction after incubation for 3 h at 3°C, but when the temperature was increased to 37°C for 1- To determine whether a membrane-bound form of the IGF2R is capable of forming dimeric complexes, a chimeric protein was engineered containing the extracytoplasmic and transmembrane domains of the IGF2R fused to the cytoplasmic domain of the EGFR. The experimental rationale was that if the chimera formed dimers, the EGFR tyrosine kinase domain would undergo autophosphorylation mediated by dimer-induced juxtaposition of the cytoplasmic domains, which we could monitor using an anti-phosphotyrosine antibody. A comparable, kinase-inactive, IGF2R/EGFR mutant chimera has been previously reported (39) . Even though this kinase-inactive chimera lacked the cytoplasmic domain of the IGF2R, it shared a very similar subcellular distribution to the wild-type IGF2R (39) . In addition, we found that the chimera bound both IGF-II and PMP-BSA with the same binding characteristics as the wild-type IGF2R (data not shown).
When expressed in 293T cells, the IGF2R/EGFR chimera demonstrated constitutive phosphorylation, consistent with the formation of oligomeric complexes. Further evidence that the phosphorylation of the chimera arises from the formation of a homodimer between two IGF2R/EGFR chimeras comes from the finding that overexpression of a Myc epitope-tagged IGF2R decreased the phosphorylation level of the IGF2R/EGFR chimera, presumably through formation of heterodimers with the chimera. The IGF2Rmyc construct coimmunoprecipitated with the IGF2R/EGFR chimera when they were coexpressed, suggesting that the cytoplasmic domain of IGF2Rmyc was not required for nor did it impede the extracytoplasmic domain's ability to form oligomeric structures. Although the finding that the chimera was capable of autophosphorylation was remarkable, it could be explained by dimerization mediated either by direct interaction between the IGF2R extracytoplasmic domains or by cross-linking mediated by binding of a bivalent Man-6-P ligand. However, like the CD-MPR, the IGF2R appears to form constitutive dimers in the cell that are not dependent upon ligand occupancy, as addition of exogenous PMP-BSA, Man-6-P, or Glc-6-P to cells transfected with the chimera had no effect on the phosphorylation level of the chimera. It is important to note that ligands added to the medium bathing the cells might have had access only to the chimeric constructs present at the cell surface. Since these receptors account for about 10% of the receptor population, the majority of the chimeric constructs might not be affected by this manipulation. Therefore, to
show that the IGF2R can form dimers in the absence of bound Man-6-P ligands, we decided to test chimeras of the IGF2R containing deletions of the Man-6-P ligand binding domains.
Analysis of IGF2R/EGFR chimeras containing truncations of the IGF2R
extracytoplasmic domain demonstrated that regions outside the Man-6-P binding domains are sufficient for the formation of receptor oligomers. The 11-TM/EGFR chimera, which lacks both
Man-6-P binding domains, behaved identically to the full-length chimera in terms of its tyrosine phosphorylation when expressed alone or with IGF2Rmyc. Whereas the tyrosine phosphorylation of the 11-TM/EGFR chimera was inhibited by overexpression of IGF2Rmyc, the 13-TM/EGFR chimera behaved differently. The 13-TM/EGFR chimera showed high levels of autophosphorylation when expressed alone, but overexpression of IGF2Rmyc had no effect on its tyrosine phosphorylation. Surprisingly, the 13-TM/EGFR did interact with IGF2Rmyc in the coimmunoprecipitation assay, although to a lesser degree than the 11-TM/EGFR. One possible explanation for these findings could be that the 13-TM/EGFR construct has a lower affinity for the full-length IGF2Rmyc, allowing for increased dissociation and re-association. Such kinetic behavior could explain why the 13-TM/EGFR construct displays high levels of tyrosine phosphorylation even in the presence of excess IGF2Rmyc. Support for this explanation comes from our previous observation that constructs that lack repeats 12-15 of the IGF2R extracytoplasmic domain formed fewer high-affinity Man-6-P binding sites than constructs containing the entire extracytoplasmic domainor near repeat 12 are important for the formation of binding-competent receptor dimers.
Whereas repeat 12 likely plays a role in the formation of dimers, other regions must be involved as well, because constructs lacking repeat 12 were capable of forming high-affinity Man-6-P binding sites 2 .
Several interesting were transferred to nitrocellulose; one blot was probed with the a-FLAG antibody and the other was probed with the a-Myc antibody to confirm expression of the constructs. The control lysates containing just IGF2Rmyc or the IGF2R/EGFR chimera were loaded in duplicate. B)
Coimmunoprecipitation and phosphorylation studies were carried out by incubating aliquots (30-50 ml) of the cell lysates containing equimolar amounts of the chimera with a-FLAG resin.
Immunoprecipitations of the control lysates containing IGF2R or the IGF2R/EGFR chimera were carried out in duplicate reactions. After immunoprecipitation, the resin pellets were washed and analyzed by SDS-PAGE and immunoblotting with a-FLAG, a-PY, or a-Myc, as indicated. 
